Pharmaceuticals, Biotechnology and Life Sciences
SAN DIEGO, May 27, 2021 (GLOBE NEWSWIRE) — AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company developing first-in-class antibody product…
Lille, France; Cambridge, MA; May 27, 2021 – GENFIT (Nasdaq and Euronext: GNFT), a late-stage biopharmaceutical company dedicated to improving…
–Data presented at AACE 2021 demonstrate patient quality of life and work productivity significantly improved in patients transitioning from injectable…
FOSTER CITY, Calif., May 27, 2021 (GLOBE NEWSWIRE) — Vaxcyte, Inc. (Nasdaq: PCVX), a next-generation vaccine company seeking to improve…
— Received $167 million in aggregate gross proceeds in April from initial public offering — – Advancing lead oncology program BMF-219,…
– Pre-launch activities continue in preparation for a potential FDA approval of TransCon™ hGH (lonapegsomatropin) for pediatric growth hormone deficiency;…
Mechelen, Belgium, 27 May 2021, 22:01 CET, – Galapagos NV (Euronext & Nasdaq: GLPG) today announced that 15 abstracts, including…
CUPERTINO, Calif., May 26, 2021 (GLOBE NEWSWIRE) — Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a clinical-stage…
Active discussions with FDA related to COVAXIN initiated late last yearMaster file submitted to FDA on March 26, 2021; awaiting…
NEW YORK, May 26, 2021 (GLOBE NEWSWIRE) — Scopus BioPharma Inc. (Nasdaq: “SCPS”) today announced it will be rescheduling the…